Moss Nicholas G, Gentle Tayler K, Arendshorst William J
Department of Cell Biology and Physiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Department of Cell Biology and Physiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Am J Physiol Renal Physiol. 2016 May 1;310(9):F832-45. doi: 10.1152/ajprenal.00461.2015. Epub 2016 Jan 28.
Renal blood flow autoregulation was investigated in anesthetized C57Bl6 mice using time- and frequency-domain analyses. Autoregulation was reestablished by 15 s in two stages after a 25-mmHg step increase in renal perfusion pressure (RPP). The renal vascular resistance (RVR) response did not include a contribution from the macula densa tubuloglomerular feedback mechanism. Inhibition of nitric oxide (NO) synthase [N(G)-nitro-l-arginine methyl ester (l-NAME)] reduced the time for complete autoregulation to 2 s and induced 0.25-Hz oscillations in RVR. Quenching of superoxide (SOD mimetic tempol) during l-NAME normalized the speed and strength of stage 1 of the RVR increase and abolished oscillations. The slope of stage 2 was unaffected by l-NAME or tempol. These effects of l-NAME and tempol were evaluated in the frequency domain during random fluctuations in RPP. NO synthase inhibition amplified the resonance peak in admittance gain at 0.25 Hz and markedly increased the gain slope at the upper myogenic frequency range (0.06-0.25 Hz, identified as stage 1), with reversal by tempol. The slope of admittance gain in the lower half of the myogenic frequency range (equated with stage 2) was not affected by l-NAME or tempol. Our data show that the myogenic mechanism alone can achieve complete renal blood flow autoregulation in the mouse kidney following a step increase in RPP. They suggest also that the principal inhibitory action of NO is quenching of superoxide, which otherwise potentiates dynamic components of the myogenic constriction in vivo. This primarily involves the first stage of a two-stage myogenic response.
采用时域和频域分析方法,对麻醉状态下的C57Bl6小鼠的肾血流自动调节进行了研究。肾灌注压(RPP)突然升高25 mmHg后,肾血流自动调节在两个阶段于15 s内重新建立。肾血管阻力(RVR)反应不包括致密斑肾小管-肾小球反馈机制的作用。抑制一氧化氮(NO)合酶[N(G)-硝基-L-精氨酸甲酯(L-NAME)]可将完全自动调节的时间缩短至2 s,并在RVR中诱导出0.25 Hz的振荡。在L-NAME作用期间淬灭超氧化物(超氧化物歧化酶模拟物tempol)可使RVR升高第一阶段的速度和强度恢复正常,并消除振荡。第二阶段的斜率不受L-NAME或tempol的影响。在RPP随机波动期间,在频域中评估了L-NAME和tempol的这些作用。抑制NO合酶可放大0.25 Hz导纳增益中的共振峰,并显著增加上肌源性频率范围(0.06 - 0.25 Hz,确定为第一阶段)的增益斜率,tempol可使其逆转。肌源性频率范围下半部分(等同于第二阶段)的导纳增益斜率不受L-NAME或tempol的影响。我们的数据表明,仅肌源性机制就能在RPP突然升高后使小鼠肾脏实现完全的肾血流自动调节。数据还表明,NO的主要抑制作用是淬灭超氧化物,否则超氧化物会在体内增强肌源性收缩的动态成分。这主要涉及两阶段肌源性反应的第一阶段。